Poly(propylacrylic acid)-peptide nanoplexes as a platform for enhancing the immunogenicity of neoantigen cancer vaccines.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Poly(propylacrylic acid)-peptide nanoplexes as a platform for enhancing the immunogenicity of neoantigen cancer vaccines.
- Published In:
- Biomaterials, 182, 82-91 (2018)
- Authors:
- Qiu, Feng, Becker, Kyle W, Knight, Frances C, Baljon, Jessalyn J, Sevimli, Sema, Shae, Daniel, Gilchuk, Pavlo, Joyce, Sebastian, Wilson, John T
- Database ID:
- RPEP-03857
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-03857APA
Qiu, Feng; Becker, Kyle W; Knight, Frances C; Baljon, Jessalyn J; Sevimli, Sema; Shae, Daniel; Gilchuk, Pavlo; Joyce, Sebastian; Wilson, John T. (2018). Poly(propylacrylic acid)-peptide nanoplexes as a platform for enhancing the immunogenicity of neoantigen cancer vaccines.. Biomaterials, 182, 82-91. https://doi.org/10.1016/j.biomaterials.2018.07.052
MLA
Qiu, Feng, et al. "Poly(propylacrylic acid)-peptide nanoplexes as a platform for enhancing the immunogenicity of neoantigen cancer vaccines.." Biomaterials, 2018. https://doi.org/10.1016/j.biomaterials.2018.07.052
RethinkPeptides
RethinkPeptides Research Database. "Poly(propylacrylic acid)-peptide nanoplexes as a platform fo..." RPEP-03857. Retrieved from https://rethinkpeptides.com/research/qiu-2018-polypropylacrylic-acidpeptide-nanoplexes-as
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.